Pro- and anti-inflammatory cytokines regulate the ERK pathway: Implication of the timing for the activation of microglial cells

Neurotoxicity Research

Volumn 8, Issue 3-4, 2005, Pages 277-287

  Saud, Katherine ^a   Herrera Molina, Rodrigo ^a   Bernhardi, Rommy ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cytokines; ERK pathway; Inflammation; Interferon; Interleukins; Lipopolysaccharide; Microglia; Neurodegeneration; Tumor necrosis factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYTOKINE; DIAGNOSTIC AGENT; ENZYME INHIBITOR; ETHIDIUM; FLAVONOID; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRITE; SUPEROXIDE; TETRAZOLIUM; TGFB1 PROTEIN, RAT; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL DEATH; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; GLIA; HIPPOCAMPUS; METABOLISM; METHODOLOGY; NERVE CELL; NEWBORN; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ETHIDIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HIPPOCAMPUS; INTERLEUKIN-1; NEUROGLIA; NEURONS; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUPEROXIDES; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33645912622     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033981     Document Type: Article

References (52)

1. Akiyama H, S Barger, S Barnum, B Bradt, J Bauer, G Cole, N Cooper, P Eikelenboom, M Emmerling, B Fiebich, C Finch, S Frautschy, W Griffin, H Hampel, M Hull, G Landreth, L Lue, R Mrak, I Mackenzie, P McGeer, M O'Banion, J Pachter, G Pasinetti, C Plata-Salaman, J Rogers, R Rydel, Y Shen, W Streit, R Strohmeyer, I Tooyoma, F Van Muiswinkel, R Veerhuis, S Walker, B Wegrzyniak, G Wenk and T Wyss-Coray (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
2. Basu A, J Krady and S Levinson (2004) Interleukin-1: A master regulator of neuroinflammation. J. Neurosci. Res. 78, 151-156.
3. Benveniste E, V Nguyen and G O'Keefe (2001) Immunological aspects of microglia: Relevance to Alzheimer's disease. Neurochem. Int. 39, 381-391.
4. Blanchette J, M Jaramillo and M Olivier (2003) Signalling events involved in interferon-γ-inducible macrophage nitric oxide generation. Immunology 108, 513-522.
5. Bruce-Keller A, J Keeling, J Keller, F Huang, S Camondola and M Mattson (2000) Antiinflammatory effects of estrogen on microglial activation. Endocrinol. 141, 3646-3656.
6. Cáceres A, G Banker, O Steward, L Binder and M Payne (1984) MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res. 315, 314-318.
7. Chao CC, S Hu and PK Peterson (1995) Modulation of human microglial cell superoxide production by cytokines. J. Leukoc. Biol. 58, 35-70.
8. Ding M, B St. Pierre, J Parkinson, P Medberry, J Wong, N Rogers, L Ignaro and J Merril (1997) Inducible nitric-oxide synthase and nitric oxide production in human foetal astrocytes and microglia. J. Biol. Chem. 272, 11327-11335.
9. Flanders K, R Ren and C Lippa (1998) Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71-85.
10. Giulian D and T Baker (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
11. Giulian D and M Corpuz (1993) Microglial secretion products and their impact on the nervous system. Adv. Neurol. 59, 315-320.
12. Giulian D and J Ingemann (1988) Colony-stimulating factors as promoters of ameboid microglia. J. Neurosci. 8, 4707-4717.
13. Giulian D, K Vaca and M Corpuz (1993) Brain glial release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
14. Giulian D, J Li, X Li, J George and P Rutecki (1994) The impact of microglia-derived cytokine upon gliosis in the CNS. Dev. Neurosci. 16, 128-136.
15. Gleizes P, J Munger, I Nunes, J Harpel, R Mazzieri, I Noguera and D Rifkin (1997) TGF-β latency: Biological significance and mechanisms of activation. Stem Cells 15, 190-197.
16. Han I-O, K-W Kim, J-H Ryu and W-K Kim (2002) p38 Mitogen-activated protein kinase mediates lipopolysaccharide, not inter-feron-γ-induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Neurosci. Lett. 325, 9-12.
17. Hazuda D, R.L. Webb, P Simon and P Young (1998) Purification and characterization of human recombinant precursor interleukin 1 beta. J. Biol. Chem. 264, 1689-1693.
18. Henrich-Noack P, J Prehn and J Krieglstein (1996) TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia. Stroke 27, 1609-1614.
19. Herrera-Molina R and R von Bernhardi (2005) Transforming growth factor-β1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol. Dis. 19, 229- 236.
20. Hu S, WS Sheng, PK Peterson and CC Chao (1995) Cytokines modulation of murine microglial cell superoxide production. Glia 13, 45-50.
21. Kaur Ch, A-J Hao, Ch-H Wu and E-A Ling (2001) Origin of microglia. Microsc. Res. Tech. 54, 2-9.
22. Lee S, W Liu, C Brosnan and D Dickinson (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12, 309-318.
23. Lieb K, S Engels and B Fiebich (2003) Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem. Int. 42, 131-137.
24. Ling E and W Wong (1993) The origin and nature of ramified and amoeboid microglia: A historical review and current concepts. Glia 7, 9-18.
25. Marcus J, S Karackattu, M Fleegal and C Summers (2003) Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: Role of Erk Mitogen-activated protein kinase and NF-κB. Glia 41, 152-160.
26. Martin L, C Pardo, L Cork and D Price (1994) Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381.
27. McCartney-Francis N and S Wahl (2002) Dysregulation of IFN-γ signaling pathways in the absence of TGF-β1. J. Immunol. 169, 5941-5947.
28. McGeer P and E McGeer (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
29. McGeer P and E McGeer (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799-809.
30. Meda L, P Baron and G Scarlato (2001) Glial activation in Alzheimer's disease: The role of Aβ and its associated proteins. Neurobiol. Aging 22, 885-893.
31. Mrak R, J Sheng and S Griffin (1995) Glial cytokines in Alzheimer's disease. Human Pathology 26, 816-823
32. Munger J, J Harpel, P Gleizes, R Mazzieri, I Nunes and D Rifkin (1997) Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int. 51, 1376-1382.
33. O'Brien M, L Lenke, J Lou, K Bridwell and M Joyce (1994) Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine 19, 2321-2329.
34. Patel AJ, S Gunasekera, A Jen and H Rohan (1996) Beta-amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. NeuroReport 7, 2026-2030.
35. Pfeiffer S, A Gorren, K Schmidt, E Werner, B Hanser, D Bohle and B Mayer (1997) Metabolic fate of peroxynitrite in aqueous solution. J. Biol. Chem. 272, 3465-3470.
36. Pyo H, I Jou, S Jung, S Hong and E-H Joe (1998) Mitogen-activated protein kinases activated by lipopolysaccharide and β-amyloid in cultured rat microglia. NeuroReport 9, 871-874.
37. Ramírez G, R Toro, H Döbeli and R von Bernhardi (2005) Protection of rat primary hippocampal cultures from Aβ cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. Neurobiol Dis. 19, 243-254.
38. Rook G (1985) A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay. J. Immunol. Methods 82, 161-167.
39. Rothwell N and G Luheshi (2000) Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends Neurosci. 23, 618-625.
40. Schubert P, T Morino, H Miyazaki, T Ogata, Y Nakamura, C Marchini and S Ferroni (2000) Cascading glia reactions: A common pathomecanism and its differentiated control by cyclic nucleotide signalling. Ann. NY. Acad. Sci. 903, 24-33.
41. Shappell N (2003) Ergovaline toxicity on CACO-2 cells as assessed by MTT, alamar blue and DNA assays. In vitro Cell Dev. Biol-animal 39, 329-335.
42. Sheng J, S Bora, G Xu, D Borchelt, D Price and V Koliatos (2003) Lipopolysaccharide-induced-neuroinflammation increases intra-cellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133-145.
43. Van Eldik L (2001) Glia and Alzheimer's disease. Neurochem. Int. 39, 329-331.
44. Vegeto E, C Bonincontro, G Polli, A Sala, S Viappiani, F Nardi, A Brusadelli, B Viviani, P Ciana and A Maggi (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21, 1809-1818.
45. Vincent V, F Tielders and A Van Dam (1997) Inhibition of endotoxin induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β. Glia 19, 190-198.
46. von Bernhardi R and J Eugenín (2004) Microglial activity to - amyloid is modulated by astrocytes and pro-inflammatory factors. Brain Res. 1025, 186-193.
47. von Bernhardi R, G Ramírez, H Matile and H Döbeli (2001) Immobilized APP constructs: A tool for the in vitro screening of glial cells reactivity. Europ. J. Neurosci. 14, 946-956.
48. ̇- induced by IFN-γ in glial cells by anti- and pro-inflammatory cytokines: The role of ERK and STAT pathways. Shanghai Int. Conf. Physiol. Biophys. Abstract book, p 127.
49. Weiner H and D Selkoe (2002) Inflammation and therapeutic vaccination in CNS diseases. Nature 420, 879-884.
50. Zhu Y, S Roth-Eichhorn, N Braun, C Culmsee, A Rami and J Krieglstein (2000) The expression of transforming growth factor-beta 1 (TGF-β1) in hippocampal neurons: A temporary upregulated protein level after transient forebrain ischemia in the rat. Brain Res. 866, 286-298.
51. Zhu Y, G Yang, B Ahlemeyer, L Pang, X Che and C Culmsee (2002) Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898-3909.
52. Zhu Y, C Culmsee, S Klumpp and J Krieglstein (2004) Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase extracellular-signal regulated kinase 1,2 signaling pathways. Neuroscience 123, 897-906.